Table 3.
Standards for L. angustifolia essential oil quality.
| Compound | European Pharmacopoeia [75] |
ISO 3515:2002 [38] | ||||
|---|---|---|---|---|---|---|
| Spontaneous Genotype |
Clonally Propagated Lavender | |||||
| France (from Seed) |
France ‘Maillette’ |
Bulgaria | Russia | Other Origins |
||
| lavandulyl acetate | >0.2 | >2 | <1.3 | 2–5 | 1–3.5 | <8 |
| lavandulol | >0.1 | >0.3 | <0.5 | >0.3 | >0.1 | <3 |
| 3-octanone | 0.1–5 | traces; <2 | 1–2.5 | 0.2–1.6 | <0.6 | <3 |
| terpinen-4-ol | 0.1–8 | 2–6 | 0.5–1.5 | 2–5 | 1.2–5 | <8 |
| linalol | 20–45 | 25–38 | 30–45 | 22–34 | 20–35 | 20–43 |
| linalyl acetate | 25–47 | 25–45 | 33–46 | 30–42 | 29–44 | 25–47 |
| limonene | <1 | <0.5 | <0.3 | <0.6 | <1 | <1 |
| camphor | <1.2 | traces; <0.5 | <1.2 | <0.6 | <0.6 | <1.5 |
| α-terpineol | <2 | <1 | 0.5–1.5 | 0.8–2 | 0.5–2 | <2 |
| 1,8-cineole | <2.5 | <1 | <0.5 | <2 | <2.5 | <3 |
| β-phellandrene | n/a | traces; <0.5 | <0.2 | <0.6 | <1 | <1 |
| cis-β-ocimene | n/a | 4–10 | <2.5 | 3–9 | 3–8 | 1–10 |
| trans-β-ocimene | n/a | 1.5–6 | <2 | 2–5 | 2–5 | 0.5–6 |
| (S)-linalyl acetate | <1 | n/a | n/a | n/a | n/a | n/a |
| (S)-linalol | <12 | n/a | n/a | n/a | n/a | n/a |
Note: numeric values in table represent %; minimum—maximum; n/a—unspecified.